Kevin Clancy

No open positions remaining

Consumer Services

Commercial Services

Finance

Profile

Mr. Clancy joined Atlas in 2006 from McKinsey & Company.
At McKinsey, he worked in the Pharmaceuticals and Medical Products practice.
He built valuation, market, and patient flow models for drug and medical device manufacturers; helping to advise corporate clients on potential acquisition opportunities as well as ongoing M&A. He received his A.B. from Harvard University and his M.Phil.
from the University of Cambridge

Former positions of Kevin Clancy

Companies	Position	End
Atlas Venture Advisors, Inc. Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements.	Private Equity Analyst	2008-12-30
McKinsey & Co., Inc. McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm	Corporate Officer/Principal	-

See the detail of Kevin Clancy's experience

Training of Kevin Clancy

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kevin Clancy's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
McKinsey & Co., Inc. McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm	Commercial Services
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Atlas Venture Advisors, Inc. Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements.	Finance